Patent US3351049A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3351049A Expired / Lapsed US ⏱️ 0.0 years remaining

Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture

Assignee: HAZLETON NUCLEAR SCIENCE CORP
•
Filing: 1965-04-12
•
Granted: 1967-11-07
•
Expires: 1985-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Donald C Lawrence

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:57
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/10; A61N5/1001; A61N5/1027; A61K; A61K51/00; A61K51/12; A61K51/1282; A61M; A61M31/00; G; G21; G21F; G21F5/00; G21F5/015; A61N2005/1019; A61N2005/1024

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 175 words
A RADIOACTIVE SEED FOR USE IN RADIATION THERAPY OF TISSUE COMPRISING A SEALED CONTAINER HAVING AN ELONGATE CAVITY THEREIN AND CONSTRUCTED WITH WALLS OF SUBSTANTIALLY UNIFORM THICKNESS, A THERAPEUTIC AMOUNT OF SOFT X-RAY EMANATING RADIOISOTOPE DISPOSED WITHIN SAID CAVITY, SAID SOFT X-RAY EMANATING ISOTOPE HAVING A CHARACTERISTIC RADIATION SUBSTANTIALLY ALL OF WHICH LIES BETWEEN ABOUT 20 KEV. AND 100 KEV. AND BEING ESSENTIALLY FREE FROM ALPHA AND BETA RADIATIONS AND HIGHER ENERGY X-RAY AND GAMMA RADIATIONS, SAID ISOTOPE HAVING A HALF-LIFE FROM ABOUT 8 TO 100 DAYS, AND MEANS DISPOSED WITHIN SAID CAVITY FOR MAINTAING SAID RADIOISOTOPE IN A SUBSTANTIALLY UNIFORM DISTRIBUTION ALONG THE LENGTH OF SAID CAVIT, SAID LAST NAMED MEANS BEING MADE OF A MATERIAL SELECTED TO HAVE LOW ABSORPTION FOR SOFT X-RAY TO THEREBY MINIMIZE INTERNAL ABSORPTION, SAID CONTAINER INCLUDING WALLS BEING MADE OF A METAL SELECTED TO HAVE A RELATIVELY LOW ATOMIC NUMBER TO THEREBY MINIMIZE THE ABSORPTION OF SOFT X-RAYS WHILE COMPLETELY CONTAINING THE ISOTOPE, SAID METAL BEING FURTHER SELECTED TO BE NONTOXIC AND NONSOLUBLE IN THE TISSUE BEING TREATED.
Claim 2
Dependent Claim 175 words
A RADIOACTIVE SEED FOR USE IN RADIATION THERAPY OF TISSUE COMPRISING A SEALED CONTAINER HAVING AN ELONGATE CAVITY THEREIN AND CONSTRUCTED WITH WALLS OF SUBSTANTIALLY UNIFORM THICKNESS, A THERAPEUTIC AMOUNT OF SOFT X-RAY EMANATING RADIOISOTOPE DISPOSED WITHIN SAID CAVITY, SAID SOFT X-RAY EMANATING ISOTOPE HAVING A CHARACTERISTIC RADIATION SUBSTANTIALLY ALL OF WHICH LIES BETWEEN ABOUT 20 KEV. AND 100 KEV. AND BEING ESSENTIALLY FREE FROM ALPHA AND BETA RADIATIONS AND HIGHER ENERGY X-RAY AND GAMMA RADIATIONS, SAID ISOTOPE HAVING A HALF-LIFE FROM ABOUT 8 TO 100 DAYS, AND MEANS DISPOSED WITHIN SAID CAVITY FOR MAINTAING SAID RADIOISOTOPE IN A SUBSTANTIALLY UNIFORM DISTRIBUTION ALONG THE LENGTH OF SAID CAVIT, SAID LAST NAMED MEANS BEING MADE OF A MATERIAL SELECTED TO HAVE LOW ABSORPTION FOR SOFT X-RAY TO THEREBY MINIMIZE INTERNAL ABSORPTION, SAID CONTAINER INCLUDING WALLS BEING MADE OF A METAL SELECTED TO HAVE A RELATIVELY LOW ATOMIC NUMBER TO THEREBY MINIMIZE THE ABSORPTION OF SOFT X-RAYS WHILE COMPLETELY CONTAINING THE ISOTOPE, SAID METAL BEING FURTHER SELECTED TO BE NONTOXIC AND NONSOLUBLE IN THE TISSUE BEING TREATED.
Claim 3
Independent Claim 60 words
A METHOD FRO MAKING A THERAPEUTICALLY RADIOACTIVE SEED COMPRISING SOAKING A NYLON CARRIER BODY OF AN ORGANIC POLYMER IS A SOLUTION CONTAINING THE RADIOACTIVE IODINE INSOTOPE I125 SO THAT SAID BODY CONTAINS A THERAPEUTIC AMOUNT OF THE I125 THEN PLACING SAID BODY AXIALLY INSIDE OF A STAINLESS STEEL TUBE, AND FUSING THE ENDS OF SAID TUBE TO SEAL THE SAME.
Claim 4
Independent Claim 60 words
A METHOD FRO MAKING A THERAPEUTICALLY RADIOACTIVE SEED COMPRISING SOAKING A NYLON CARRIER BODY OF AN ORGANIC POLYMER IS A SOLUTION CONTAINING THE RADIOACTIVE IODINE INSOTOPE I125 SO THAT SAID BODY CONTAINS A THERAPEUTIC AMOUNT OF THE I125 THEN PLACING SAID BODY AXIALLY INSIDE OF A STAINLESS STEEL TUBE, AND FUSING THE ENDS OF SAID TUBE TO SEAL THE SAME.

References Cited (Backward Citations)

US1494826A Cited
US2328105A Cited
US2814296A Cited
US2811471A Cited
US3121041A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1970-11-06 1971-05-08 1971-11-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1974-11-06 1975-05-08 1975-11-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1978-11-06 1979-05-08 1979-11-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag